<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancers</z:e> with Ras mutations represent a major therapeutic problem </plain></SENT>
<SENT sid="1" pm="."><plain>Recent RNAi screens have uncovered multiple nononcogene <z:mp ids='MP_0002555'>addiction</z:mp> pathways that are necessary for the survival of Ras mutant cells </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we identify the evolutionarily conserved gene enhancer of rudimentary homolog (ERH), in which <z:mpath ids='MPATH_63'>depletion</z:mpath> causes greater toxicity in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells with mutations in the small GTPase KRAS compared with KRAS WT cells </plain></SENT>
<SENT sid="3" pm="."><plain>ERH interacts with the spliceosome protein SNRPD3 and is required for the <z:chebi fb="2" ids="33699">mRNA</z:chebi> splicing of the mitotic motor protein CENP-E </plain></SENT>
<SENT sid="4" pm="."><plain>Loss of ERH leads to loss of CENP-E and consequently, chromosome congression defects </plain></SENT>
<SENT sid="5" pm="."><plain>Gene expression profiling indicates that ERH is required for the expression of multiple cell cycle genes, and the gene expression signature resulting from ERH down-regulation inversely correlates with KRAS signatures </plain></SENT>
<SENT sid="6" pm="."><plain>Clinically, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> ERH expression is inversely associated with survival of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> harbor KRAS mutations </plain></SENT>
<SENT sid="7" pm="."><plain>Together, these findings identify a role of ERH in <z:chebi fb="2" ids="33699">mRNA</z:chebi> splicing and mitosis, and they provide evidence that KRAS mutant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells are dependent on ERH for their survival </plain></SENT>
</text></document>